hypericin has been researched along with EHS Tumor in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypericin, a potent necrosis avid agent, features a peculiar affinity for necrotic tissue." | 7.74 | Exploration of the mechanism underlying the tumor necrosis avidity of hypericin. ( De Witte, PA; Ni, Y; Van de Putte, M, 2008) |
| "Hypericin, a potent necrosis avid agent, features a peculiar affinity for necrotic tissue." | 3.74 | Exploration of the mechanism underlying the tumor necrosis avidity of hypericin. ( De Witte, PA; Ni, Y; Van de Putte, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B | 1 |
| Roskams, T | 1 |
| de Witte, PA | 2 |
| Van de Putte, M | 1 |
| Ni, Y | 1 |
2 other studies available for hypericin and EHS Tumor
| Article | Year |
|---|---|
Antivascular tumor eradication by hypericin-mediated photodynamic therapy.
Topics: Animals; Anthracenes; Blood Vessels; Disease Models, Animal; Female; Laser Therapy; Mice; Mice, Inbr | 2002 |
Exploration of the mechanism underlying the tumor necrosis avidity of hypericin.
Topics: Animals; Anthracenes; Carbocyanines; Female; Fibrosarcoma; Lipoproteins; Mice; Mice, Inbred C3H; Nec | 2008 |